FCM
IMA

Farallon Capital Management’s ImageneBio Inc IMA Stock Holding History

Farallon Capital Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24,167
Closed -$1.28M – 315
2022
Q2 		$1.28M Sell
24,167
-41,839
-63% -$2.31M 0.01% 213
2022
Q1 		$4.83M Sell
66,006
-24,103
-27% -$2.56M 0.02% 189
2021
Q4 		$13.6M Sell
90,109
-3,003
-3% -$487K 0.07% 113
2021
Q3 		$22.4M Hold
93,112
– – 0.1% 97
2021
Q2 		$15.7M Sell
93,112
-19,347
-17% -$4.27M 0.06% 108
2021
Q1 		$38.1M Buy
+112,459
New +$38.5M 0.19% 81

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Farallon Capital Management's IMA Position: Q3 2022 in Review

Farallon Capital Management sold out of ImageneBio Inc (IMA) in Q3 2022, closing a stake of 24,167 shares — an estimated $1.28M sold.

Farallon Capital Management first reported a position in IMA in Q1 2021 and held it in 6 quarters. The position peaked at $38.1M in Q1 2021. 42 funds tracked by Wall St. Rank hold IMA as of Q3 2022.

  • Farallon Capital Management reported no remaining ImageneBio Inc position as of Q3 2022 after selling out during the quarter.
  • Farallon Capital Management sold 24,167 ImageneBio Inc shares in Q3 2022, an estimated $1.28M.
  • Farallon Capital Management first reported a position in ImageneBio Inc in Q1 2021 and held it in 6 quarters.
  • Farallon Capital Management's ImageneBio Inc position peaked at $38.1M in Q1 2021.
  • 42 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2022.

Based on Farallon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.